TransPharm Preclinical Solutions

Transferring scientific knowledge from the real world to the classroom has been at the heart of a new partnership formed this summer between…

Nanoviricides' drug candidates led to complete survival of small animals lethally infected with an aggressive and neurotropic strain of HSV-1.

We've got spring feVRE! Many bacteria live in our gut and on our skin, usually without causing problems. However, serious infections can occur when…

SASP: Efficacy of Pa SASPject against Pseudomonas aeruginosa ATCC 27853 in a Mouse Lung Model Phico Therapeutics

Efficacy and Impact to the Microbiome of Novel Specifically-Targeted Antimicrobial Peptides against C. difficile Infection C3J Therapeutics

Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile Broad Institute of MIT and Harvard

Subcutaneous (SC) Injection of CD101, a Novel Echinocandin: Efficacious, Well-Tolerated, and Sustained Drug Exposures Cidara Therapeutics

January 2017 marked our 9 year anniversary and the close of another great year here at TransPharm. With 17 new clients in 2016, the TransPharm family…

Another year has gone by and 2015 is right around the corner. This January marks our seven-year anniversary. It is hard to believe that eight years…